Viewing Study NCT00907166

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2026-05-09 @ 1:30 PM
Study NCT ID: NCT00907166
Status: TERMINATED
Last Update Posted: 2017-03-21
First Post: 2009-05-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients
Sponsor: Cornerstone Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Pancreatic Cancer View
None Pancreatic Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cornerstone Pharmaceuticals, Inc. View
None CPI-613 View
None Altered Energy Metabolism Directed Compound View
None Phase I View
None Phase II View
None Cancer View
None Carcinoma of the Pancreas View
None Pancreatic Cancer View
None Pancreatic Carcinoma View